Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 24;12(17):2141.
doi: 10.3390/cells12172141.

The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development

Affiliations
Review

The Highs and Lows of FBXW7: New Insights into Substrate Affinity in Disease and Development

Claire C de la Cova. Cells. .

Abstract

FBXW7 is a critical regulator of cell cycle, cell signaling, and development. A highly conserved F-box protein and component of the SKP1-Cullin-F-box (SCF) complex, FBXW7 functions as a recognition subunit within a Cullin-RING E3 ubiquitin ligase responsible for ubiquitinating substrate proteins and targeting them for proteasome-mediated degradation. In human cells, FBXW7 promotes degradation of a large number of substrate proteins, including many that impact disease, such as NOTCH1, Cyclin E, MYC, and BRAF. A central focus for investigation has been to understand the molecular mechanisms that allow the exquisite substrate specificity exhibited by FBXW7. Recent work has produced a clearer understanding of how FBXW7 physically interacts with both high-affinity and low-affinity substrates. We review new findings that provide insights into the consequences of "hotspot" missense mutations of FBXW7 that are found in human cancers. Finally, we discuss how the FBXW7-substrate interaction, and the kinases responsible for substrate phosphorylation, contribute to patterned protein degradation in C. elegans development.

Keywords: E3 ubiquitin ligase; FBXW7/FBW7/Cdc4/SEL-10; phospho-degron; ubiquitin–proteasome system.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
FBXW7 interaction with high and low-affinity substrates. (A) Domains of the FBXW7 protein include three different N-termini produced from alternative isoforms and common regions that include the dimerization domain, F-box domain, and WD40 repeat domain. The SCF-FBXW7 E3 ubiquitin ligase is a complex comprising FBXW7, SKP1, CUL1, and RBX1. This complex is capable of recruiting an E2 ubiquitin ligase through RBX1 and CUL1. FBXW7 acts as the substrate recognition component, binding a substrate CPD. (BD) Examples of FBXW7 binding with high and low affinity. At left, the FBXW7 WD40 repeat domain surface is semi-transparent, with sidechains involved in CPD binding shown (blue). The CPD peptide (tan) sidechains are shown for P-2, P-1, P0, and P+4 positions. Red is used to indicate negative charges. At right, FBXW7 binding residues (blue) and CPD (tan) are shown without the surface rendering. (B) The high-affinity CPD at Cyclin E T380 contains three components: P-2, P-1 hydrophobic leucines, P0 pThr, and P+4 pSer. Binding is coordinated by FBXW7 residues Y519, R505, R479, R465, T463, S462, and R441. (C) The low-affinity CPD at MYC T244 has negatively charged glutamates rather than hydrophobic residues at P-2 and P-1. (D) The low affinity CPD at Cyclin T62 does not contain a phosphorylated P+4 residue. In this structure, positions after P+1 were disordered. Illustrations were generated from PDB accessions 2OVQ, 7TY1, 2OVR [10,14].
Figure 2
Figure 2
Patterns of FBXW7 degradation for high- and low-affinity substrates. (A) The C. elegans Raf ortholog LIN-45 contains one known CPD that conforms to t he high-affinity consensus. LIN-45 protein and conserved domains (green), including the Ras-binding domain (RBD), the cysteine-rich domain (CRD), and the kinase domain (KD). CPD sequence is shown below. (B) At the C. elegans L3 larval stage, a population of cells termed VPCs express LIN-45 protein (green). Although initially expressed in all VPCs, LIN-45 is degraded in one denoted P6.p. Degradation of LIN-45 requires the C. elegans FBXW7 ortholog SEL-10 and the kinases ERK, CDK2, and GSK3. At the L3 stage, elimination of LIN-45 closely matches the pattern of ERK activation, with high ERK activation and LIN-45 degradation both occurring specifically in P6.p ERK activation is summarized as low or high for each cell (magenta). (C) The C. elegans RNA-binding TRIM71 ortholog LIN-41 contains multiple, non-consensus degrons. LIN-41 protein and conserved domains (orange), including the NHL repeats (NHL). Degron A, B1, and B2 are non-overlapping regions required for LIN-41 degradation and enriched in Ser/Thr-Pro sequences. (D) During C. elegans oogenesis, maturing oocytes in late prophase express LIN-41 protein (orange). LIN-41 is seen in oocytes just after fertilization but is rapidly eliminated as they complete the first division of meiosis. LIN-41 degradation requires SEL-10 and the kinase CDK1. Activation of CDK1 is presumed to increase as oocytes progress from late prophase to the meiosis I division, as summarized for late prophase, fertilization, and meiosis I (blue). In contrast, LIN-41 degradation occurs precisely at the division of meiosis I. Illustrations summarize data from [43,47].

References

    1. Ravid T., Hochstrasser M. Diversity of degradation signals in the ubiquitin-proteasome system. Nat. Rev. Mol. Cell Biol. 2008;9:679–690. doi: 10.1038/nrm2468. - DOI - PMC - PubMed
    1. Dikic I., Robertson M. Ubiquitin ligases and beyond. BMC Biol. 2012;10:22. doi: 10.1186/1741-7007-10-22. - DOI - PMC - PubMed
    1. Lydeard J.R., Schulman B.A., Harper J.W. Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 2013;14:1050–1061. doi: 10.1038/embor.2013.173. - DOI - PMC - PubMed
    1. Skaar J.R., Pagan J.K., Pagano M. Mechanisms and function of substrate recruitment by F-box proteins. Nat. Rev. Mol. Cell Biol. 2013;14:369–381. doi: 10.1038/nrm3582. - DOI - PMC - PubMed
    1. Yumimoto K., Nakayama K.I. Recent insight into the role of FBXW7 as a tumor suppressor. Semin. Cancer Biol. 2020;67:1–15. doi: 10.1016/j.semcancer.2020.02.017. - DOI - PubMed

Publication types